Provided by Tiger Trade Technology Pte. Ltd.

TOUYUN BIOTECH

0.118
+0.0032.61%
Volume:4.99M
Turnover:585.78K
Market Cap:331.11M
PE:-3.76
High:0.127
Open:0.120
Low:0.112
Close:0.115
52wk High:0.750
52wk Low:0.067
Shares:2.81B
HK Float Shares:2.80B
Volume Ratio:0.26
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.031
ROE:-265.02%
ROA:-5.94%
PB:-5.19
PE(LYR):-3.76
PS:2.31

Loading ...

Touyun Biotech Group Ltd. Announces Strategic Focus on Prudent Capital Deployment, Enhanced Risk Management, and Concentration in Financial Services Sector to Maximise Shareholder Value

Reuters
·
Jan 30

TOUYUN BIOTECH (01332) Shareholder Transfers Shares from Mingji Securities to CMB Wing Lung Bank, Portfolio Value Reaches HK$26.82 Million

Stock News
·
Jan 28

TOUYUN BIOTECH (01332) Plunges Over 60% on Heavy Volume Following Recent Share Transfers and Deposits

Stock News
·
Jan 23

TOUYUN BIOTECH (01332) Shareholder Transfers Shares from Wutong Securities to KGI Asia, Portfolio Valued at HK$35.35 Million

Stock News
·
Jan 21

Touyun Biotech Group Fails to Repay RMB150 Million Loan and Seeks Extension

Reuters
·
Dec 11, 2025

Touyun Biotech Group Limited (01332) Releases Monthly Return for 30 November 2025

Bulletin Express
·
Dec 02, 2025

TOUYUN BIOTECH (01332) Surges Over 80% Intraday After Securing RMB 1 Billion Chlorella Product Orders

Stock News
·
Nov 12, 2025

Touyun Biotech Clarifies Unusual Share Movements and Confirms Normal Operations

Reuters
·
Nov 03, 2025

Hong Kong Stocks: 52-Week Highs and Lows as of November 3

Stock News
·
Nov 03, 2025

TOUYUN BIOTECH (01332) Surges Over 81% Again, Nearly 9-Fold Rally in Three Days After Signing RMB 1 Billion Chlorella Order

Stock News
·
Nov 03, 2025

HK Stock Surge | TOUYUN BIOTECH (01332) Soars Over 70% in Afternoon Trading After Signing RMB 1 Billion Chlorella Product Order

Stock News
·
Oct 31, 2025

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 31%

Simply Wall St.
·
Oct 13, 2025

Touyun Biotech Group Ltd. Issues Quarterly Update on Action Plan to Address Audit Qualification and Enhance Product Distribution

Reuters
·
Sep 30, 2025

TOUYUN BIOTECH (01332) Reports Interim Results with Shareholders' Attributable Profit of HK$11.243 Million, Turning Profitable Year-on-Year

Stock News
·
Aug 22, 2025

Touyun Biotech Group H1 Revenue HKD 36.6 Million

THOMSON REUTERS
·
Aug 22, 2025

Touyun Biotech Group H1 Gross Margin 37%

THOMSON REUTERS
·
Aug 22, 2025